1. Academic Validation
  2. Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasis

Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasis

  • Life Sci Alliance. 2022 Jan 4;5(3):e202101256. doi: 10.26508/lsa.202101256.
Sampath Katakam 1 Santosh Anand 2 Patricia Martin 1 Nicolo Riggi 1 Ivan Stamenkovic 3
Affiliations

Affiliations

  • 1 Experimental Pathology Service, Centre Hospitalier Universitaire Vaudois and Department of Research and Education, University of Lausanne, Lausanne, Switzerland.
  • 2 Department of Informatics, Systems, and Communications (DISCo), University of Milano-Bicocca, Milan, Italy.
  • 3 Experimental Pathology Service, Centre Hospitalier Universitaire Vaudois and Department of Research and Education, University of Lausanne, Lausanne, Switzerland Ivan.Stamenkovic@unil.ch.
Abstract

Malignant tumors commonly display necrosis, which invariably triggers an inflammatory response that supports tumor growth. However, the effect on tumor cells of necrotic debris, or damage-associated molecular patterns (DAMPs) released by dying cells is unknown. Here, we addressed the effect of DAMPs on primary Ewing sarcoma (EwS) cells and cell lines grown in 3D (spheroids) and 2D culture. We show that DAMPs promote the growth of EwS spheroids but not 2D cultures and that the underlying mechanism implicates an increase in Cholesterol load in spheroids. In contrast, stimulation of the nucleic acid sensor signaling platform STING by its ligand cyclic GMP-AMP decreases the tumor cell Cholesterol load and reduces their tumor initiating ability. Overexpression of STING or stimulation with cyclic GMP-AMP opposes the growth stimulatory effect of DAMPs and synergizes with the Cholesterol synthesis inhibitor simvastatin to inhibit tumor growth. Our observations show that modulation of Cholesterol homeostasis is a major effect of necrotic cell debris and STING and suggest that combining STING agonists with statins may help control tumor growth.

Figures
Products